FM
DGX icon

Forward Management’s Quest Diagnostics DGX Stock Holding History

Forward Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-43,895
Closed -$2.87M – 273
2015
Q2 		$2.87M Sell
43,895
-31,340
-42% -$2.31M 0.18% 83
2015
Q1 		$4.38M Sell
75,235
-12,725
-14% -$911K 0.26% 63
2014
Q4 		$5.04M Buy
87,960
+7,165
+9% +$452K 0.27% 56
2014
Q3 		$4.63M Buy
80,795
+11,340
+16% +$699K 0.28% 60
2014
Q2 		$3.95M Buy
+69,455
New +$4.07M 0.23% 62

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Forward Management's DGX Position: Q3 2015 in Review

Forward Management sold out of Quest Diagnostics (DGX) in Q3 2015, closing a stake of 43,895 shares — an estimated $2.87M sold.

Forward Management first reported a position in DGX in Q2 2014 and held it in 5 quarters. The position peaked at $5.04M in Q4 2014. 540 funds tracked by Wall St. Rank hold DGX as of Q3 2015.

  • Forward Management reported no remaining Quest Diagnostics position as of Q3 2015 after selling out during the quarter.
  • Forward Management sold 43,895 Quest Diagnostics shares in Q3 2015, an estimated $2.87M.
  • Forward Management first reported a position in Quest Diagnostics in Q2 2014 and held it in 5 quarters.
  • Forward Management's Quest Diagnostics position peaked at $5.04M in Q4 2014.
  • 540 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2015.

Based on Forward Management's 13F filing for Q3 2015, filed 9 Nov 2015.